232 related articles for article (PubMed ID: 11397874)
1. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: alterations in cortisol pharmacokinetics at puberty.
Charmandari E; Hindmarsh PC; Johnston A; Brook CG
J Clin Endocrinol Metab; 2001 Jun; 86(6):2701-8. PubMed ID: 11397874
[TBL] [Abstract][Full Text] [Related]
2. Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory?
Charmandari E; Matthews DR; Johnston A; Brook CG; Hindmarsh PC
J Clin Endocrinol Metab; 2001 Oct; 86(10):4679-85. PubMed ID: 11600525
[TBL] [Abstract][Full Text] [Related]
3. Flutamide decreases cortisol clearance in patients with congenital adrenal hyperplasia.
Charmandari E; Calis KA; Keil MF; Mohassel MR; Remaley A; Merke DP
J Clin Endocrinol Metab; 2002 Jul; 87(7):3197-200. PubMed ID: 12107224
[TBL] [Abstract][Full Text] [Related]
4. Cortisol and 17-hydroxyprogesterone kinetics in saliva after oral administration of hydrocortisone in children and young adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Gröschl M; Rauh M; Dörr HG
J Clin Endocrinol Metab; 2002 Mar; 87(3):1200-4. PubMed ID: 11889188
[TBL] [Abstract][Full Text] [Related]
5. Oral hydrocortisone administration in children with classic 21-hydroxylase deficiency leads to more synchronous joint GH and cortisol secretion.
Charmandari E; Pincus SM; Matthews DR; Johnston A; Brook CG; Hindmarsh PC
J Clin Endocrinol Metab; 2002 May; 87(5):2238-44. PubMed ID: 11994370
[TBL] [Abstract][Full Text] [Related]
6. Classic congenital adrenal hyperplasia and puberty.
Charmandari E; Brook CG; Hindmarsh PC
Eur J Endocrinol; 2004 Nov; 151 Suppl 3():U77-82. PubMed ID: 15554890
[TBL] [Abstract][Full Text] [Related]
7. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM; Simm D; Beier C; Dörr HG
Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Charmandari E; Johnston A; Brook CG; Hindmarsh PC
J Endocrinol; 2001 Apr; 169(1):65-70. PubMed ID: 11250647
[TBL] [Abstract][Full Text] [Related]
9. Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty.
Bonfig W; Bechtold S; Schmidt H; Knorr D; Schwarz HP
J Clin Endocrinol Metab; 2007 May; 92(5):1635-9. PubMed ID: 17299071
[TBL] [Abstract][Full Text] [Related]
10. Bone mineral density and body composition in congenital adrenal hyperplasia.
Cameron FJ; Kaymakci B; Byrt EA; Ebeling PR; Warne GL; Wark JD
J Clin Endocrinol Metab; 1995 Jul; 80(7):2238-43. PubMed ID: 7608286
[TBL] [Abstract][Full Text] [Related]
11. Management of altered hydrocortisone pharmacokinetics in a boy with congenital adrenal hyperplasia using a continuous subcutaneous hydrocortisone infusion.
Bryan SM; Honour JW; Hindmarsh PC
J Clin Endocrinol Metab; 2009 Sep; 94(9):3477-80. PubMed ID: 19567522
[TBL] [Abstract][Full Text] [Related]
12. Effect of carbenoxolone on the plasma renin activity and hypothalamic-pituitary-adrenal axis in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Irony I; Cutler GB
Clin Endocrinol (Oxf); 1999 Sep; 51(3):285-91. PubMed ID: 10469007
[TBL] [Abstract][Full Text] [Related]
13. Hydrocortisone dosing during puberty in patients with classical congenital adrenal hyperplasia: an evidence-based recommendation.
Bonfig W; Pozza SB; Schmidt H; Pagel P; Knorr D; Schwarz HP
J Clin Endocrinol Metab; 2009 Oct; 94(10):3882-8. PubMed ID: 19622620
[TBL] [Abstract][Full Text] [Related]
14. [Puberty and growth development in patients with a 21-hydroxylase defect].
Börger D; Willig RP
Monatsschr Kinderheilkd; 1985 Nov; 133(11):828-33. PubMed ID: 2934617
[TBL] [Abstract][Full Text] [Related]
15. Normal bone mineral density and lean body mass, but increased fat mass, in young adult patients with congenital adrenal hyperplasia.
Stikkelbroeck NM; Oyen WJ; van der Wilt GJ; Hermus AR; Otten BJ
J Clin Endocrinol Metab; 2003 Mar; 88(3):1036-42. PubMed ID: 12629082
[TBL] [Abstract][Full Text] [Related]
16. Variation in absorption and half-life of hydrocortisone influence plasma cortisol concentrations.
Hindmarsh PC; Charmandari E
Clin Endocrinol (Oxf); 2015 Apr; 82(4):557-61. PubMed ID: 25369980
[TBL] [Abstract][Full Text] [Related]
17. Treatment with flutamide decreases cortisol clearance: implications for therapy in congenital adrenal hyperplasia.
Charmandari E; Johnston A; Honour JW; Brook CG; Hindmarsh PC
J Pediatr Endocrinol Metab; 2002 Apr; 15(4):435-9. PubMed ID: 12008691
[TBL] [Abstract][Full Text] [Related]
18. Sexual dimorphism in the synchrony of joint growth hormone and cortisol dynamics in children with classic 21-hydroxylase deficiency.
Charmandari E; Pincus SM; Matthews DR; Johnston A; Brook CG; Hindmarsh PC
J Pediatr Endocrinol Metab; 2003; 16(8):1119-30. PubMed ID: 14594172
[TBL] [Abstract][Full Text] [Related]
19. The effects of glucocorticoid replacement therapy on growth, bone mineral density, and bone turnover markers in children with congenital adrenal hyperplasia.
Girgis R; Winter JS
J Clin Endocrinol Metab; 1997 Dec; 82(12):3926-9. PubMed ID: 9398689
[TBL] [Abstract][Full Text] [Related]
20. Gender related differences in glucocorticoid therapy and growth outcomes among pubertal children with 21-hydroxylase deficiency congenital adrenal hyperplasia (CAH).
Deslauriers JR; Lenz AM; Root AW; Diamond FB; Bercu BB
J Pediatr Endocrinol Metab; 2012; 25(9-10):977-81. PubMed ID: 23426829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
